Home Cart 0 Sign in  

[ CAS No. 68867-17-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 68867-17-4
Chemical Structure| 68867-17-4
Structure of 68867-17-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 68867-17-4 ]

Related Doc. of [ 68867-17-4 ]

Alternatived Products of [ 68867-17-4 ]

Product Details of [ 68867-17-4 ]

CAS No. :68867-17-4 MDL No. :MFCD06796380
Formula : C8H5NO2S Boiling Point : -
Linear Structure Formula :- InChI Key :RBIZQDIIVYJNRS-UHFFFAOYSA-N
M.W : 179.20 Pubchem ID :2735460
Synonyms :

Calculated chemistry of [ 68867-17-4 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 46.58
TPSA : 78.43 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.3 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.35
Log Po/w (XLOGP3) : 1.54
Log Po/w (WLOGP) : 1.99
Log Po/w (MLOGP) : 1.03
Log Po/w (SILICOS-IT) : 2.49
Consensus Log Po/w : 1.68

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -2.41
Solubility : 0.697 mg/ml ; 0.00389 mol/l
Class : Soluble
Log S (Ali) : -2.8
Solubility : 0.286 mg/ml ; 0.0016 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.34
Solubility : 0.815 mg/ml ; 0.00455 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.74

Safety of [ 68867-17-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 68867-17-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 68867-17-4 ]
  • Downstream synthetic route of [ 68867-17-4 ]

[ 68867-17-4 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 103261-70-7 ]
  • [ 68867-17-4 ]
YieldReaction ConditionsOperation in experiment
94% With sodium hydroxide In tetrahydrofuran; methanol; water at 20℃; for 18 h; To a solution of ethyl 1,3-benzothiazole-5-carboxylate (5.30 g, 25.6 mmol) in a mixture of methanol (150 mL), tetrahydrofuran (40 mL) and water (5 mL) was added a 50percent aqueous solution of sodium hydroxide (10 mL). The mixture was maintained at rt for 18 h and was concentrated. The residue was partitioned between water (300 mL) and diethyl ether (200 mL) and the organic layer was removed. Concentrated hydrochloric acid was added to the aqueous layer to adjust the pH to 4 and the mixture was extracted with ethyl acetate (3 x 300 mL). The combined extracts were washed with brine (200 mL), dried over anhydrous sodium sulfate, and concentrated to yield 4.30 g (94percent) the acid.
94%
Stage #1: With sodium hydroxide; water In tetrahydrofuran; methanol at 20℃; for 18 h;
Stage #2: With hydrogenchloride In water
To a solution of 4-chloro-3-nitrobenzoic acid (99.2 mmol) in N, N-dimethylformamide (400 mL) was added potassium carbonate (254 mmol). After 30 min, ethyl iodide (119 mmol) was added and the reaction mixture was heated at 50 °C for 4 h. Water (3 L) was added and the mixture was extracted with diethyl ether (2 x 500 mL). The organic extracts were combined, washed with brine (1 L), dried over anhydrous sodium sulfate and concentrated. The residue was crystallized from hexanes, thus providing the ester in 86percent yield.'H NMR (500 MHz, CDC13) 8 8. 51 (d, 1H), 8.17 (dd, 1H), 7.65 (d, 1H), 4.43 (q, 2H), 1.42 (t, 3H). Sulfur (49.91 mmol) was dissolved in a solution of sodium sulfide nonahydrate (49.96 mmol) in water (60 mL). This solution was combined with a solution of ethyl 4-chloro- 3-nitrobenzoate (85.36 mmol) in ethanol (100 mL) and the resulting mixture was heated at reflux for 3 h. The hot reaction mixture was poured into water (600 mL) and maintained for 15 min. The product was isolated by filtration and recrystallized from ethanol, thus providing the disulfide in 77percent yield. 1H NMR (500 MHz, CDC13) 8 8.96 (d, 1H), 8.19 (dd, 1H), 7.88 (d, 1H), 4.43 (q, 2H), 1.41 (t, 3H). A mixture of diethyl 4,4'-dithiobis (3-nitrobenzoate) (24.8 mmol) and zinc granules (234 mmol) in formic acid (600 mL) was heated to reflux for 48 h. The mixture was allowed to cool to room temperature and concentrated to dryness. The residue was partitioned between ethyl acetate (500 mL) and saturated aqueous sodium bicarbonate (500 mL). The organic layer was separated, dried over anhydrous sodium sulfate and concentrated. The residue was chromatographed on neutral Alumina (1/1 to 0/1 hexanes/dichloromethane), thus providing the thiazole in 51percent yields NMR (500 MHz, CDCl3) 5 9. 08 (s, 1H), 8.83 (d, 1H), 8.14 (dd, 1H), 8.02 (d, 1H), 4.45 (q, 2H), 1.44 (t, 3H); MS (EI) nilz 208 (M++1). To a solution of ethyl 1, 3-benzothiazole-5-carboxylate (25.6 mmol) in a mixture of methanol (150 mL), tetrahydrofuran (40 mL) and water (5 mL) was added a 50percent aqueous solution of sodium hydroxide (10 mL). The mixture was maintained at rt for 18 h and was concentrated. The residue was partitioned between water (300 mL) and diethyl ether (200 mL) and the organic layer was removed. Concentrated hydrochloric acid was added to the aqueous layer to adjust the pH to 4 and the mixture was extracted with ethyl acetate (3 x 300 mL). The combined extracts were washed with brine (200 mL), dried over anhydrous sodium sulfate, and concentrated thus providing the acid in 94percent yield.
Reference: [1] Patent: WO2004/29050, 2004, A1, . Location in patent: Page 67
[2] Patent: WO2005/92890, 2005, A2, . Location in patent: Page/Page column 70-71
  • 2
  • [ 478169-65-2 ]
  • [ 68867-17-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 24, p. 8219 - 8248
  • 3
  • [ 96-99-1 ]
  • [ 68867-17-4 ]
Reference: [1] Patent: US2004/38998, 2004, A1,
  • 4
  • [ 64-18-6 ]
  • [ 96-99-1 ]
  • [ 68867-17-4 ]
Reference: [1] Patent: WO2003/87098, 2003, A1, . Location in patent: Page/Page column 67
  • 5
  • [ 14719-83-6 ]
  • [ 68867-17-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 24, p. 8219 - 8248
  • 6
  • [ 35350-37-9 ]
  • [ 68867-17-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 24, p. 8219 - 8248
  • 7
  • [ 2942-16-7 ]
  • [ 68867-17-4 ]
Reference: [1] Zhurnal Obshchei Khimii, 1956, vol. 26, p. 3388,3390; engl. Ausg. S. 3773
  • 8
  • [ 68867-17-4 ]
  • [ 394223-38-2 ]
Reference: [1] Patent: WO2015/66371, 2015, A1,
  • 9
  • [ 68867-17-4 ]
  • [ 394223-37-1 ]
Reference: [1] Patent: WO2015/66371, 2015, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 68867-17-4 ]

Carboxylic Acids

Chemical Structure| 3622-35-3

[ 3622-35-3 ]

Benzo[d]thiazole-6-carboxylic acid

Similarity: 0.97

Chemical Structure| 24851-69-2

[ 24851-69-2 ]

2-Methylbenzo[d]thiazole-5-carboxylic acid

Similarity: 0.91

Chemical Structure| 1393576-38-9

[ 1393576-38-9 ]

2-Chlorobenzo[d]thiazole-5-carboxylic acid

Similarity: 0.90

Chemical Structure| 1379324-66-9

[ 1379324-66-9 ]

2-Chlorobenzo[d]thiazole-7-carboxylic acid

Similarity: 0.86

Chemical Structure| 677304-83-5

[ 677304-83-5 ]

Benzo[d]thiazole-7-carboxylic acid

Similarity: 0.83